Solid Tumors
📧 Sign up to get email alerts when something new happens for Solid Tumors.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: A Phase 1/2 Study of GW5282 in Participants With Advanced Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating GW5282 in participants with advanced solid tumors is currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: HEAT Trial (HER2 Antibody Therapy With Lutetium-177) [EARLY_Phase 1]
This update announces that the HEAT trial, a Phase 1 study of a HER2-targeted antibody therapy with Lutetium-177, is currently recruiting fo…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: A Phase 1b/2 Multisite Dose-finding and Expansion Study of WTX-330 in Adult Patients With Selected Advanced or Metastatic Solid Tumors or Lymphoma [Phase 1, Phase 2]
Phase 1b/2 multisite dose-finding and expansion study of WTX-330 in adults with selected advanced or metastatic solid tumors or Non-Hodgkin …
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Genomic Profiling in Cancer Patients
Clinical trial update from Memorial Sloan Kettering Cancer Center describes genomic profiling in cancer patients and indicates the study is …
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of BAT8008 for Injection [Phase 1]
Phase 1 clinical trial update for BAT8008 evaluating safety, tolerability, and pharmacokinetics. The study is currently recruiting in patien…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Phase I/II Randomized Study of NBTXR3 Activated by Abscopal or RadScopal Radiation in Combination With Immunotherapy (Anti-PD-1/L-1) for Patients With Advanced Solid Malignancies [Phase 1, Phase 2]
This ClinicalTrials.gov update describes a Phase I/II randomized study evaluating NBTXR3 activated by abscopal or RadScopal radiation in com…
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
A SWOG trial is recruiting to develop a method for predicting toxicity risk from immune checkpoint inhibitors in patients with malignant sol…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: A Study of SH009 Injection in Patients With Advanced Solid Tumors. [Phase 1]
A Phase 1 clinical trial update for SH009 Injection in patients with advanced solid tumors, currently recruiting across multiple indications…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: A Study of mRNA-4106 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Solid Tumors [Phase 1]
Phase 1 trial evaluating mRNA-4106 alone and in combination with immune checkpoint blockade in participants with solid tumors; the study is …
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: Phase II Study of LM-24C5 [Phase 2]
Phase II study of LM-24C5 for advanced solid tumors is currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: A Safety and Efficacy Study of HCB101, Fc-fusion Protein Targeting SIRPα-CD47 Pathway, in Solid or Hematological Tumors [Phase 1]
Phase 1 safety and efficacy study of HCB101, an Fc-fusion protein targeting the SIRPα-CD47 pathway, in advanced solid tumors and refractory …
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: Safety Trial of 68Ga/177Lu-NRT6020 in FAP-Positive Advanced Solid Tumor Patients [Phase 1]
Phase 1 safety trial in FAP-positive advanced solid tumors using 68Ga/177Lu-NRT6020 is currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: National Register of Actionable Mutations
This entry describes a National Registry of Actionable Mutations clinical trial led by the Federation of Italian Cooperative Oncology Groups…
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: A Study of HDM2006 in Patients With Advanced Solid Tumor [Phase 1]
This entry describes a Phase 1 clinical trial evaluating the investigational drug HDM2006 in patients with advanced solid tumors. The study …
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: Genetic Testing for the Prevention of Cancer in Indigenous American Communities (JUNIPER Trial) [NA]
The JUNIPER Trial, sponsored by Mayo Clinic, is evaluating genetic testing for cancer prevention in Indigenous American communities and is c…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Study to Evaluate CD8 PET Imaging as a Marker of Immune Response to Stereotactic Body Radiation Therapy (ELIXR) [Phase 1]
Phase 1 clinical trial evaluating CD8 PET imaging as a biomarker of immune response to stereotactic body radiation therapy in patients with …
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors [Phase 1, Phase 2]
This clinical trial update reports a Phase Ib/II study of TCC1727 in combination therapy for advanced solid tumors, including non-small cell…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors [Phase 1, Phase 2]
A Phase 1/2a study evaluating DB-1303/BNT323 in HER2-positive advanced solid tumors is currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-27Clinical Trial Update: First-in-Human Study of ICT01 in Patients With Advanced Cancer [Phase 1, Phase 2]
First-in-human study of ICT01 in patients with advanced cancer; Phase 1/2 trial, currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: Comparative Effectiveness of Verbal Instruction Versus Simulation Video Education Among Cancer Patients Undergoing Radiation Therapy [NA]
This clinical trial update describes a comparative effectiveness study evaluating verbal instruction versus simulation video education for c…
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: A Phase I First-in-Human Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Anti-Tumor Activity of SWA1211 Tablets in Subjects With Advanced Solid Tumors [Phase 1]
This document describes a Phase I first-in-human, open-label trial evaluating safety, tolerability, pharmacokinetics, and preliminary anti-t…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: First-in-human Phase I to Evaluate PEP-010 as Single Agent and in Combination With Paclitaxel or With Gemcitabine (CleverPeptide) [EARLY_Phase 1]
This is a first-in-human Phase I trial of PEP-010 as a single agent and in combination with paclitaxel or gemcitabine for metastatic solid t…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: A Study of MRG006A in the Treatment of Patients With Advanced Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating MRG006A in patients with advanced solid tumors is currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: A Study of APS03118 in Advanced Solid Tumors Harboring RET Mutations or Fusions [Phase 1]
This clinical trial update describes a Phase 1 study of APS03118 in advanced solid tumors harboring RET mutations or fusions, with recruitme…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: A Study to Test the Safety and Tolerability of SBO-154 in Patients With Advanced Solid Tumors. [Phase 1]
A Phase 1 study is evaluating the safety and tolerability of SBO-154 in patients with advanced solid tumors, and the trial is currently recr…